Benzinga | Sep 10, 2020 06:55AM EDT

Morgan Stanley Initiates Coverage On Axsome Therapeutics with Overweight Rating, Announces Price Target of $102

Morgan Stanley analyst Vikram Purohit initiates coverage on Axsome Therapeutics (NASDAQ:AXSM) with a Overweight rating and announces Price Target of $102.